Ascendis Pharma Total Liabilities and Share Holders Equity 2015-2024 | ASND
Ascendis Pharma total liabilities and share holders equity for the quarter ending June 30, 2024 was $0.817B, a 9.09% decline year-over-year.
- Ascendis Pharma total liabilities and share holders equity for 2023 was $0.894B, a 22.18% decline from 2022.
- Ascendis Pharma total liabilities and share holders equity for 2022 was $1.148B, a 10.55% decline from 2021.
- Ascendis Pharma total liabilities and share holders equity for 2021 was $1.284B, a 14.68% increase from 2020.